Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutaminergic and Histaminergic Modulation in Acute Ischemic Stroke
NCT02142712Phase 2Completed
- Sponsor
- University of Florida
- Start
- Dec 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dextromethorphan and diphenhydramine in ischemic stroke (4 arms), sponsored by University of Florida. Primary endpoints: Modified Rankin Scale at 3 months, National Institutes of Health Stroke Scale at 3 months and 2 more. Started Dec 2014; status: completed.
02
Drugs
dextromethorphandiphenhydramine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02142712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02142712.